New 2024 Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight Johannes Schetelig Group Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author Johannes Schetelig Journal Front Immunol.
New 2024 Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC) Group Chronic Malignancies Working Party (CMWP) 1st listed author Christian Niederwieser Journal Bone Marrow Transplant.
New 2024 Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP Group Paediatric Diseases Working Party (PDWP) 1st listed author Jacek Wachowiak Journal Bone Marrow Transplant.
New 2024 Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation Group Infectious Diseases Working Party (IDWP) 1st listed author Julien De Greef Journal J Infect.
New 2024 Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal Am J Hematol.
New 2024 Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Juan Montoro Journal Blood.
New 2024 Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey Group Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author P Comoli Journal Ann Oncol.
New 2024 Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
New 2024 Listeria monocytogenes infections in hematopoietic cell transplant recipients: clinical manifestations and risk factors: A multinational retrospective case control study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Group Infectious Diseases Working Party (IDWP) 1st listed author Dina Averbuch Journal Transplant Cell Ther.
2024 ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus-host disease in adults Group Transplant Complications Working Party (TCWP) Patient Advocacy Committee 1st listed author Saskia Bos Journal Eur Respir J.
2024 Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Enrico Maffini Journal Bone Marrow Transplant.
2024 HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties Group Severe Aplastic Anaemia Working Party (SAAWP) Paediatric Diseases Working Party (PDWP) 1st listed author Stefano Giardino Journal Am J Hematol.